SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-001803
Filing Date
2022-01-13
Accepted
2022-01-12 20:04:19
Documents
4
Period of Report
2022-01-13

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea153941-6k_immuron.htm 6-K 12526
2 IMMURON RECEIVES EUROPEAN PATENT ON DRUG TO TREAT DIARRHEA ea153941ex99-1_immuron.htm EX-99.1 15200
3 GRAPHIC image_002.jpg GRAPHIC 8969
4 GRAPHIC image_003.jpg GRAPHIC 1682
  Complete submission text file 0001213900-22-001803.txt   43689
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 22527619
SIC: 2834 Pharmaceutical Preparations